The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A Biomimetic Drug Delivery System by Integrating Grapefruit Extracellular Vesicles and Doxorubicin-Loaded Heparin-Based Nanoparticles for Glioma Therapy
Abstract
Existing nanoparticle-mediated drug delivery systems for glioma systemic chemotherapy remain a great challenge due to poor delivery efficiency resulting from the blood brain barrier/blood-(brain tumor) barrier (BBB/BBTB) and insufficient tumor penetration. Here, we demonstrate a distinct design by patching doxorubicin-loaded heparin-based nanoparticles (DNs) onto the surface of natural grapefruit extracellular vesicles (EVs), to fabricate biomimetic EV-DNs, achieving efficient drug delivery and thus significantly enhancing antiglioma efficacy. The patching strategy allows the unprecedented 4-fold drug loading capacity compared to traditional encapsulation for EVs. The biomimetic EV-DNs are enabled to bypass BBB/BBTB and penetrate into glioma tissues by receptor-mediated transcytosis and membrane fusion, greatly promoting cellular internalization and antiproliferation ability as well as extending circulation time. We demonstrate that a high-abundance accumulation of EV-DNs can be detected at glioma tissues, enabling the maximal brain tumor uptake of EV-DNs and great antiglioma efficacy in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
van Tellingen, O., Yetkin-Arik, B., de Gooijer, M. C., Wesseling, P., Wurdinger, T., & de Vries, H. E. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.02.002 · Cited by 1,035
Jang, S. C., Kim, O. Y., Yoon, C. M., Choi, D.-S., Roh, T.-Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.-K., & Gho, Y. S. (2013) · ACS Nano · doi:10.1021/nn402232g · Cited by 1,022
Yang, T., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., Yin, V. P., Lockman, P., & Bai, S. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1593-y · Cited by 975
Sarma, J. V., & Ward, P. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1034-0 · Cited by 974
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
Smyth, T., Kullberg, M., Malik, N., Smith-Jones, P., Graner, M. W., & Anchordoquy, T. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.013 · Cited by 722
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 721
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Modelling of the blood–brain barrier in drug discovery and development
Cecchelli, R., Berezowski, V., Lundquist, S., Culot, M., Renftel, M., Dehouck, M.-P., & Fenart, L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2368 · Cited by 618
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
Wang, Q., Zhuang, X., Mu, J., Deng, Z.-B., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., et al. (2013) · Nature Communications · doi:10.1038/ncomms2886 · Cited by 525
The dose threshold for nanoparticle tumour delivery
Ouyang, B., Poon, W., Zhang, Y.-N., Lin, Z. P., Kingston, B. R., Tavares, A. J., Zhang, Y., Chen, J., Valic, M. S., Syed, A. M., et al. (2020) · Nature Materials · doi:10.1038/s41563-020-0755-z · Cited by 514
Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy
Qi, H., Liu, C., Long, L., Ren, Y., Zhang, S., Chang, X., Qian, X., Jia, H., Zhao, J., Sun, J., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b06939 · Cited by 459
Zhuang, X., Teng, Y., Samykutty, A., Mu, J., Deng, Z., Zhang, L., Cao, P., Rong, Y., Yan, J., Miller, D., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2015.188 · Cited by 294
Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models
Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0154 · Cited by 282
A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer
Li, Y., Gao, Y., Gong, C., Wang, Z., Xia, Q., Gu, F., Hu, C., Zhang, L., Guo, H., & Gao, S. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.05.020 · Cited by 222
Heparin and modified heparin inhibit complement activation in vivo
Weiler, J. M., Edens, R. E., Linhardt, R. J., & Kapelanski, D. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.10.3210 · Cited by 220
Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency
Schindler, C., Collinson, A., Matthews, C., Pointon, A., Jenkinson, L., Minter, R. R., Vaughan, T. J., & Tigue, N. J. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214545 · Cited by 200
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
Srivastava, A., Amreddy, N., Babu, A., Panneerselvam, J., Mehta, M., Muralidharan, R., Chen, A., Zhao, Y. D., Razaq, M., Riedinger, N., et al. (2016) · Scientific Reports · doi:10.1038/srep38541 · Cited by 187
Extracellular vesicles induce minimal hepatotoxicity and immunogenicity
Saleh, A. F., Lázaro-Ibáñez, E., Forsgard, M. A.-M., Shatnyeva, O., Osteikoetxea, X., Karlsson, F., Heath, N., Ingelsten, M., Rose, J., Harris, J., et al. (2019) · Nanoscale · doi:10.1039/c8nr08720b · Cited by 185
Active transcytosis and new opportunities for cancer nanomedicine
Pandit, S., Dutta, D., & Nie, S. (2020) · Nature Materials · doi:10.1038/s41563-020-0672-1 · Cited by 181
Stem Cell-Based Human Blood–Brain Barrier Models for Drug Discovery and Delivery
Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P., & Ferreira, L. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.01.001 · Cited by 169
Kanchanapally, R., Deshmukh, S. K., Chavva, S. R., Tyagi, N., Srivastava, S. K., Patel, G. K., Singh, A. P., & Singh, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s191313 · Cited by 157
Exosomal Doxorubicin Reduces the Cardiac Toxicity of Doxorubicin
Toffoli, G., Hadla, M., Corona, G., Caligiuri, I., Palazzolo, S., Semeraro, S., Gamini, A., Canzonieri, V., & Rizzolio, F. (2015) · Nanomedicine · doi:10.2217/nnm.15.118 · Cited by 156
pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery
Lee, H., Park, H., Noh, G. J., & Lee, E. S. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.141 · Cited by 152
Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment
Pinel, S., Thomas, N., Boura, C., & Barberi‐Heyob, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.013 · Cited by 148
Targeted delivery of doxorubicin to HER2 positive tumor models
Gomari, H., Forouzandeh Moghadam, M., Soleimani, M., Ghavami, M., & Khodashenas, S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210731 · Cited by 111
Zhang, D., Qin, X., Wu, T., Qiao, Q., Song, Q., & Zhang, Z. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.024 · Cited by 108
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine
Feng, J., Lepêtre‐Mouelhi, S., Gautier, A., Mura, S., Cailleau, C., Coudoré, F., Hamon, M., & Couvreur, P. (2019) · Science Advances · doi:10.1126/sciadv.aau5148 · Cited by 98
In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes
Han, H., LEE, A., SONG, C., HWANG, T., Seong, H., Lee, C.-L., & SHIN, B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.007 · Cited by 93
Covalent nano delivery systems for selective imaging and treatment of brain tumors
Ljubimova, J. Y., Sun, T., Mashouf, L. A., Ljubimov, A. V., Israel, L. L., Ljubimov, V. A., Falahatian, V., & Holler, E. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.002 · Cited by 83
Fluorescent lipid probes in the study of viral membrane fusion
Blumenthal, R., Gallo, S. A., Viard, M., Raviv, Y., & Puri, A. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00019-1 · Cited by 65
Chen, H., Luo, Q., Wang, J., He, H., Luo, W., Zhang, L., Xiao, Q., Chen, T., Xu, X., Niu, W., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c05724 · Cited by 24
Self-citation
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
Self-citationAdvances in nanomaterial-based targeted drug delivery systems
Cheng, X., Xie, Q., & Sun, Y. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1177151 · Cited by 395
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Cong, M., Tan, S., Li, S., Gao, L., Huang, L., Zhang, H.-G., & Qiao, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114108 · Cited by 302
Metadata
- Authors
- Niu, W., Xiao, Q., Wang, X., Zhu, J., Li, J., Liang, X., Peng, Y., Wu, C., Lu, R., Pan, Y., Luo, J., Zhong, X., He, H., Rong, Z., Fan, J.-B., & Wang, Y.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-01-21
- Volume
- 21
- Issue
- 3
- Pages
- 1484-1492
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W3122880728
- Cited by
- 372
- References
- 37
- FWCI
- 14.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.